OCX logo

OncoCyte (OCX) Revenue

Annual Revenue

$1.50 M
+$545.00 K+56.89%

December 31, 2023


Summary


Performance

OCX Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherOCXprofitabilitymetrics:

Quarterly Revenue

$115.00 K
+$11.00 K+10.58%

September 30, 2024


Summary


Performance

OCX Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

Related metrics

TTM Revenue

$709.00 K
-$314.00 K-30.69%

September 30, 2024


Summary


Performance

OCX TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherOCXprofitabilitymetrics:

OCX Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+56.9%-73.2%-51.5%
3 y3 years+23.6%-51.5%+309.1%
5 y5 years--51.5%+309.1%

OCX Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-31.6%+56.9%-75.2%+105.9%-67.7%+156.4%
5 y5-year-31.6%+56.9%-94.3%+105.9%-84.7%+156.4%
alltimeall time-31.6%+56.9%-94.3%+105.9%-84.7%+156.4%

OncoCyte Revenue History

DateAnnualQuarterlyTTM
Sep 2024
-
$115.00 K(+10.6%)
$709.00 K(-30.7%)
Jun 2024
-
$104.00 K(-40.9%)
$1.02 M(-26.0%)
Mar 2024
-
$176.00 K(-43.9%)
$1.38 M(-8.1%)
Dec 2023
$1.50 M(+56.9%)
$314.00 K(-26.8%)
$1.50 M(+2.7%)
Sep 2023
-
$429.00 K(-7.3%)
$1.46 M(+32.9%)
Jun 2023
-
$463.00 K(+55.9%)
$1.10 M(+25.8%)
Mar 2023
-
$297.00 K(+8.4%)
$875.00 K(-8.7%)
Dec 2022
$958.00 K
$274.00 K(+309.0%)
$958.00 K(-176.3%)
Sep 2022
-
$67.00 K(-71.7%)
-$1.26 M(+270.5%)
DateAnnualQuarterlyTTM
Jun 2022
-
$237.00 K(-37.6%)
-$339.00 K(-123.3%)
Mar 2022
-
$380.00 K(-119.6%)
$1.45 M(-33.8%)
Dec 2021
$2.20 M(+80.8%)
-$1.94 M(-297.2%)
$2.20 M(-52.6%)
Sep 2021
-
$984.00 K(-51.5%)
$4.64 M(+10.2%)
Jun 2021
-
$2.03 M(+80.6%)
$4.21 M(+81.2%)
Mar 2021
-
$1.12 M(+123.5%)
$2.33 M(+91.0%)
Dec 2020
$1.22 M
$503.00 K(-9.4%)
$1.22 M(+70.4%)
Sep 2020
-
$555.00 K(+288.1%)
$714.00 K(+349.1%)
Jun 2020
-
$143.00 K(+793.8%)
$159.00 K(+893.8%)
Mar 2020
-
$16.00 K
$16.00 K

FAQ

  • What is OncoCyte annual revenue?
  • What is the all time high annual revenue for OncoCyte?
  • What is OncoCyte annual revenue year-on-year change?
  • What is OncoCyte quarterly revenue?
  • What is the all time high quarterly revenue for OncoCyte?
  • What is OncoCyte quarterly revenue year-on-year change?
  • What is OncoCyte TTM revenue?
  • What is the all time high TTM revenue for OncoCyte?
  • What is OncoCyte TTM revenue year-on-year change?

What is OncoCyte annual revenue?

The current annual revenue of OCX is $1.50 M

What is the all time high annual revenue for OncoCyte?

OncoCyte all-time high annual revenue is $2.20 M

What is OncoCyte annual revenue year-on-year change?

Over the past year, OCX annual revenue has changed by +$545.00 K (+56.89%)

What is OncoCyte quarterly revenue?

The current quarterly revenue of OCX is $115.00 K

What is the all time high quarterly revenue for OncoCyte?

OncoCyte all-time high quarterly revenue is $2.03 M

What is OncoCyte quarterly revenue year-on-year change?

Over the past year, OCX quarterly revenue has changed by -$314.00 K (-73.19%)

What is OncoCyte TTM revenue?

The current TTM revenue of OCX is $709.00 K

What is the all time high TTM revenue for OncoCyte?

OncoCyte all-time high TTM revenue is $4.64 M

What is OncoCyte TTM revenue year-on-year change?

Over the past year, OCX TTM revenue has changed by -$754.00 K (-51.54%)